ATE455086T1 - Verfahren zur stabilisierung von reduziertem coenzym q10 und verfahren zur sauren kristallisation - Google Patents

Verfahren zur stabilisierung von reduziertem coenzym q10 und verfahren zur sauren kristallisation

Info

Publication number
ATE455086T1
ATE455086T1 AT02746041T AT02746041T ATE455086T1 AT E455086 T1 ATE455086 T1 AT E455086T1 AT 02746041 T AT02746041 T AT 02746041T AT 02746041 T AT02746041 T AT 02746041T AT E455086 T1 ATE455086 T1 AT E455086T1
Authority
AT
Austria
Prior art keywords
reduced coenzyme
acid
crystalization
stabilizing reduced
stabilizing
Prior art date
Application number
AT02746041T
Other languages
English (en)
Inventor
Takahiro Ueda
Shiro Kitamura
Yasuyoshi Ueda
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Application granted granted Critical
Publication of ATE455086T1 publication Critical patent/ATE455086T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/26Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/34Separation; Purification; Stabilisation; Use of additives
    • C07C41/40Separation; Purification; Stabilisation; Use of additives by change of physical state, e.g. by crystallisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/34Separation; Purification; Stabilisation; Use of additives
    • C07C41/46Use of additives, e.g. for stabilisation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
AT02746041T 2001-07-16 2002-07-15 Verfahren zur stabilisierung von reduziertem coenzym q10 und verfahren zur sauren kristallisation ATE455086T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001215804 2001-07-16
JP2002114878 2002-04-17
PCT/JP2002/007148 WO2003008363A1 (fr) 2001-07-16 2002-07-15 Procede de stabilisation d'une coenzyme q10 reduite et technique de cristallisation en presence d'acide

Publications (1)

Publication Number Publication Date
ATE455086T1 true ATE455086T1 (de) 2010-01-15

Family

ID=26618815

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02746041T ATE455086T1 (de) 2001-07-16 2002-07-15 Verfahren zur stabilisierung von reduziertem coenzym q10 und verfahren zur sauren kristallisation

Country Status (11)

Country Link
US (1) US7169590B2 (de)
EP (1) EP1415973B1 (de)
JP (1) JP4149917B2 (de)
KR (1) KR20040018464A (de)
CN (1) CN1254462C (de)
AT (1) ATE455086T1 (de)
AU (1) AU2002318516B2 (de)
CA (1) CA2453135A1 (de)
DE (1) DE60235089D1 (de)
TW (1) TWI235146B (de)
WO (1) WO2003008363A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI305547B (en) 2001-12-27 2009-01-21 Kaneka Corp Processes for producing coenzyme q10
TW200302056A (en) * 2002-01-18 2003-08-01 Kaneka Corp Method for stabilizing reduced coenzyme Q10 and composition therefor
US7358402B2 (en) * 2003-09-10 2008-04-15 Kaneka Corporation Reduced coenzyme Q10 crystal with excellent stability and composition containing said reduced coenzyme Q10 crystal
KR101395370B1 (ko) 2004-01-22 2014-05-14 유니버시티 오브 마이애미 국소용 코-엔자임 큐10 제형 및 그의 사용 방법
US20060147542A1 (en) * 2004-12-24 2006-07-06 Tadao Ono Solid preparation containing reduced coenzyme Q10 and method for producing the same
US8067217B2 (en) 2004-12-28 2011-11-29 Kaneka Corporation Method for preserving reduced coenzyme Q10
WO2007126086A1 (ja) * 2006-04-28 2007-11-08 Kaneka Corporation 還元型補酵素q10の精製方法
MX337408B (es) 2007-03-22 2016-03-03 Berg Llc Formulaciones topicas que tienen biodisponibilidad aumentada.
MX2010011032A (es) 2008-04-11 2011-03-01 Cytotech Labs Llc Star Metodos y uso de induccion de apoptosis en celulas cancerigenas.
CN101307338B (zh) * 2008-07-17 2012-04-25 任雷 还原型辅酶q10的制备方法
CN102481271A (zh) 2009-05-11 2012-05-30 博格生物系统有限责任公司 利用表观代谢转变剂、多维细胞内分子或环境影响剂治疗代谢障碍的方法
SG10202010355PA (en) 2010-03-12 2020-11-27 Berg Llc Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
KR101038916B1 (ko) * 2011-03-17 2011-06-07 노새미 콘크리트 저수조의 짜임공법식 내벽 마감구조
CA2832324C (en) 2011-04-04 2022-03-15 Berg Llc Methods of treating central nervous system tumors
EP2720680B1 (de) 2011-06-17 2020-02-12 Berg LLC Inhalbierbare pharmazeutische zusammensetzungen
DK2725004T3 (en) * 2011-06-24 2018-04-16 Kaneka Corp REDUCED COENZYM Q10 CRYSTAL WITH EXCELLENT STABILITY
NZ713868A (en) 2013-04-08 2021-12-24 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
KR102370843B1 (ko) 2013-09-04 2022-03-04 버그 엘엘씨 코엔자임 q10의 연속주입에 의한 암치료 방법
WO2017087576A1 (en) 2015-11-16 2017-05-26 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
CN105833793B (zh) * 2015-12-21 2019-04-02 神舟生物科技有限责任公司 一种工业生产辅酶q10的工艺方法
US11498893B2 (en) * 2018-09-28 2022-11-15 Kaneka Corporation Production method for crystal of reduced coenzyme Q10 having excellent stability
CN113024362B (zh) * 2021-03-10 2022-02-15 中国科学院上海药物研究所 一种辅酶qh与烟酰胺的共晶及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6712642A (de) * 1966-09-17 1968-03-18
JPS5915894B2 (ja) 1975-12-15 1984-04-12 ニツシンセイフン カブシキガイシヤ ホコウソqノセイゾウホウホウ
JPS609796B2 (ja) 1977-04-21 1985-03-13 日清製粉株式会社 補酵素qの製造法
JPS56140947A (en) * 1980-04-03 1981-11-04 Sekisui Chem Co Ltd Production of coenzyme q
CA2207093A1 (en) 1994-12-06 1996-06-13 National Research Council Of Canada Water soluble ubiquinone compositions, prodrugs, and methods relating thereto
JP3889481B2 (ja) 1996-08-16 2007-03-07 株式会社カネカ 医薬組成物
US8753675B1 (en) 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications

Also Published As

Publication number Publication date
DE60235089D1 (de) 2010-03-04
EP1415973A4 (de) 2006-02-01
CA2453135A1 (en) 2003-01-30
TWI235146B (en) 2005-07-01
JPWO2003008363A1 (ja) 2004-11-04
WO2003008363A1 (fr) 2003-01-30
EP1415973A1 (de) 2004-05-06
EP1415973B1 (de) 2010-01-13
US20040197418A1 (en) 2004-10-07
CN1254462C (zh) 2006-05-03
JP4149917B2 (ja) 2008-09-17
US7169590B2 (en) 2007-01-30
AU2002318516B2 (en) 2007-12-06
CN1525951A (zh) 2004-09-01
AU2002318516A2 (en) 2003-03-03
KR20040018464A (ko) 2004-03-03

Similar Documents

Publication Publication Date Title
ATE455086T1 (de) Verfahren zur stabilisierung von reduziertem coenzym q10 und verfahren zur sauren kristallisation
ATE511508T1 (de) Verfahren zur kristallisation von (r)- oder (s)- lansoprazol
EE200300578A (et) Plasmi(i)n(ogeeni) eemaldamine valgulahustest
BRPI0418002A (pt) processo de seqüestro de carbono sob a forma de um mineral no qual o carbono está no grau de oxidação +3"
ATE261946T1 (de) Verfahren zur herstellung von thiazolidin
DE69931753D1 (de) Azoverbindungen sowie verfahren zur herstellung derselben
ATE554178T1 (de) Verfahren zur herstellung von aminosäurederivaten aus hydroxyiminosäuren
DE502005006938D1 (de) Verfahren zur Herstellung von aliphatischen geradkettigen und ß-alkylverzweigten Carbonsäuren
DE60233664D1 (de) Verfahren zur herstellung von pyridinverbindungen
DE60207490D1 (de) Verfahren zur Herstellung von (Meth)Acrylsäureanhydrid
DE69205842D1 (de) Verfahren zur herstellung von flunixin und zwischenprodukten dafür.
ATE271533T1 (de) Verfahren zur herstellung von alkincarbonsäuren durch oxidation von alkinalkoholen
ATE446308T1 (de) Verfahren zur herstellung von cinnamylaldehyd- derivaten und ihre verwendung
BR9913720A (pt) Processo de purificação por cristalização ourecristalização de ácidos carboxìlicos
DE60238056D1 (de) Verfahren zum kristallisieren von reduziertem coenzym q10 aus wässriger lösung
DE60100217D1 (de) Verfahren zur Herstellung von hochkonzentrierten Kohlendioxid
ATE529392T1 (de) Verfahren zur oxidation von kohlenwasserstoffen in carbonsäuren
DE60040592D1 (de) Verfahren zur herstellung von alpha-aminoketonen
DE602004018417D1 (de) Verfahren zur Herstellung von Sulfinyl- oder Sulfonyl- Verbindungen in Gegenwart von epsilon-Phthalimidoperhexansäure
DE69925836D1 (de) Ein verfahren zur herstellung von 4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-carbonsäure
DE68921163D1 (de) Isolierung von L-Phenylalanin aus dessen racemischen Mischungen.
ATE455753T1 (de) Verfahren zur herstellung einer aromatischen nitrilverbindung
DE602004012764D1 (de) Verfahren zur herstellung von glyceraldehydacetonid
EP1650195A4 (de) Verfahren zur inhibierung der produktion von osteopontin
DE59904211D1 (de) Verfahren zur Reinigung und Isolierung von 2,3,5-Trimethyl-p-benzochinon

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties